Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis

Details for Australian Patent Application No. 2004297594 (hide)

Owner Memorial Sloan-Kettering Cancer Center

Inventors Xing, Hongmei R.; Kolesncik, Richard N.

Agent Madderns

Pub. Number AU-B-2004297594

PCT Pub. Number WO2005/056756

Priority 10/727,358 03.12.03 US

Filing date 3 December 2004

Wipo publication date 23 June 2005

Acceptance publication date 17 December 2009

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/056756 Priority application(s): WO2005/056756

17 December 2009 Application Accepted

  Published as AU-B-2004297594

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004297596-Quick-connect cartridge assembly with plug

2004297593-A method for homogenous charge compression ignition start of combustion control